International Biotechnology Trust Past Earnings Performance
Past criteria checks 2/6
International Biotechnology Trust's earnings have been declining at an average annual rate of -7.6%, while the Capital Markets industry saw earnings growing at 14.9% annually. Revenues have been declining at an average rate of 4% per year. International Biotechnology Trust's return on equity is 2.5%, and it has net margins of 65.1%.
Key information
-7.6%
Earnings growth rate
-8.3%
EPS growth rate
| Capital Markets Industry Growth | 16.3% |
| Revenue growth rate | -4.0% |
| Return on equity | 2.5% |
| Net Margin | 65.1% |
| Last Earnings Update | 31 Aug 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How International Biotechnology Trust makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Aug 23 | 10 | 7 | 4 | 0 |
| 31 May 23 | 31 | 25 | 4 | 0 |
| 28 Feb 23 | 51 | 43 | 4 | 0 |
| 30 Nov 22 | 19 | 10 | 4 | 0 |
| 31 Aug 22 | -14 | -22 | 4 | 0 |
| 31 May 22 | -24 | -31 | 4 | 0 |
| 28 Feb 22 | -35 | -40 | 4 | 0 |
| 30 Nov 21 | -1 | -6 | 4 | 0 |
| 31 Aug 21 | 32 | 28 | 4 | 0 |
| 31 May 21 | 49 | 46 | 4 | 0 |
| 28 Feb 21 | 66 | 63 | 4 | 0 |
| 30 Nov 20 | 61 | 58 | 3 | 0 |
| 31 Aug 20 | 55 | 53 | 3 | 0 |
| 31 May 20 | 37 | 34 | 3 | 0 |
| 29 Feb 20 | 18 | 15 | 3 | 0 |
| 30 Nov 19 | 2 | -1 | 3 | 0 |
| 31 Aug 19 | -13 | -18 | 3 | 0 |
| 31 May 19 | 4 | 0 | 3 | 0 |
| 28 Feb 19 | 22 | 18 | 3 | 0 |
| 30 Nov 18 | 22 | 19 | 3 | 0 |
| 31 Aug 18 | 22 | 20 | 3 | 0 |
| 31 May 18 | 6 | 5 | 2 | 0 |
| 28 Feb 18 | -10 | -11 | 2 | 0 |
| 30 Nov 17 | 20 | 17 | 3 | 0 |
| 31 Aug 17 | 49 | 45 | 4 | 0 |
| 31 May 17 | 62 | 57 | 4 | 0 |
| 28 Feb 17 | 76 | 70 | 5 | 0 |
| 30 Nov 16 | 37 | 31 | 4 | 0 |
| 31 Aug 16 | -1 | -7 | 4 | 0 |
| 31 May 16 | -17 | -22 | 3 | 0 |
| 29 Feb 16 | -32 | -37 | 3 | 0 |
| 30 Nov 15 | 26 | 21 | 4 | 0 |
| 31 Aug 15 | 84 | 78 | 5 | 0 |
| 31 May 15 | 85 | 80 | 5 | 0 |
| 28 Feb 15 | 87 | 81 | 5 | 0 |
| 30 Nov 14 | 67 | 63 | 4 | 0 |
| 31 Aug 14 | 48 | 45 | 3 | 0 |
| 31 May 14 | 58 | 55 | 3 | 0 |
| 28 Feb 14 | 67 | 64 | 3 | 0 |
| 30 Nov 13 | 57 | 54 | 3 | 0 |
| 31 Aug 13 | 47 | 44 | 3 | 0 |
| 31 May 13 | 40 | 38 | 2 | 0 |
Quality Earnings: IBT has high quality earnings.
Growing Profit Margin: IBT became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: IBT's earnings have declined by 7.6% per year over the past 5 years.
Accelerating Growth: IBT has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: IBT has become profitable in the last year, making it difficult to compare its past year earnings growth to the Capital Markets industry (-12.2%).
Return on Equity
High ROE: IBT's Return on Equity (2.5%) is considered low.